Literature DB >> 8707089

Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat.

J D Butzner1, R Parmar, C J Bell, V Dalal.   

Abstract

BACKGROUND: The short chain fatty acid (SCFA) butyrate provides energy for colonocytes, stimulates colonic fluid and electrolyte absorption and is recognised as an effective treatment for multiple types of colitis. AIM: To examine the impact of butyrate enema therapy on the clinical course, severity of inflammation, and SCFA stimulated Na+ absorption in a chronic experimental colitis.
METHODS: Distal colitis was induced in rats with a trinitrobenzenesulphonic acid (TNBS) enema. Five days after induction, rats were divided into groups to receive: no treatment, saline enemas, or 100 mM Na-butyrate enemas daily. On day 24, colonic damage score and tissue myeloperoxidase (MPO) activity were evaluated. Colon was mounted in Ussing chambers and Na+ transport and electrical activities were measured during a basal period and after stimulation with 25 mM butyrate.
RESULTS: In the untreated and the saline enema treated TNBS groups, diarrhoea and extensive colonic damage were seen, associated with increased tissue MPO activities and absent butyrate stimulated Na+ absorption. In contrast, in the butyrate enema treated TNBS group, diarrhoea ceased, colonic damage score improved, and tissue MPO activity as well as butyrate stimulated Na+ absorption recovered to control values.
CONCLUSION: Butyrate enema therapy stimulated colonic repair, as evidenced by clinical recovery, decreased inflammation, and restoration of SCFA stimulated electrolyte absorption.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8707089      PMCID: PMC1383116          DOI: 10.1136/gut.38.4.568

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

Review 1.  Bacterial short chain fatty acids: their role in gastrointestinal disease.

Authors:  B S Ramakrishna; W E Roediger
Journal:  Dig Dis       Date:  1990       Impact factor: 2.404

2.  Metabolic induction of experimental ulcerative colitis by inhibition of fatty acid oxidation.

Authors:  W E Roediger; S Nance
Journal:  Br J Exp Pathol       Date:  1986-12

3.  Hapten-induced model of chronic inflammation and ulceration in the rat colon.

Authors:  G P Morris; P L Beck; M S Herridge; W T Depew; M R Szewczuk; J L Wallace
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

Review 4.  Energy contributions of volatile fatty acids from the gastrointestinal tract in various species.

Authors:  E N Bergman
Journal:  Physiol Rev       Date:  1990-04       Impact factor: 37.312

Review 5.  Volatile fatty acids: their production, absorption, utilization, and roles in human health.

Authors:  S E Fleming; D S Arce
Journal:  Clin Gastroenterol       Date:  1986-10

6.  Short-chain fatty acids stimulate active sodium and chloride absorption in vitro in the rat distal colon.

Authors:  H J Binder; P Mehta
Journal:  Gastroenterology       Date:  1989-04       Impact factor: 22.682

7.  Rectal irrigation with short-chain fatty acids for distal ulcerative colitis. Preliminary report.

Authors:  R I Breuer; S K Buto; M L Christ; J Bean; P Vernia; P Paoluzi; M C Di Paolo; R Caprilli
Journal:  Dig Dis Sci       Date:  1991-02       Impact factor: 3.199

8.  Effect of short-chain fatty acids on the human colonic mucosa in vitro.

Authors:  W Scheppach; P Bartram; A Richter; F Richter; H Liepold; G Dusel; G Hofstetter; J Rüthlein; H Kasper
Journal:  JPEN J Parenter Enteral Nutr       Date:  1992 Jan-Feb       Impact factor: 4.016

9.  Exacerbation of experimental colitis by nonsteroidal anti-inflammatory drugs is not related to elevated leukotriene B4 synthesis.

Authors:  J L Wallace; C M Keenan; D Gale; T S Shoupe
Journal:  Gastroenterology       Date:  1992-01       Impact factor: 22.682

10.  Stimulation of intestinal mucosal growth with intracolonic infusion of short-chain fatty acids.

Authors:  S A Kripke; A D Fox; J M Berman; R G Settle; J L Rombeau
Journal:  JPEN J Parenter Enteral Nutr       Date:  1989 Mar-Apr       Impact factor: 4.016

View more
  52 in total

1.  Effect of Sishen Pill on Memory T Cells From Experimental Colitis Induced by Dextran Sulfate Sodium.

Authors:  Wei Ge; Hai-Yan Wang; Hai-Mei Zhao; Xue-Ke Liu; You-Bao Zhong; Jian Long; Zheng-Yun Zuo; Duan-Yong Liu
Journal:  Front Pharmacol       Date:  2020-07-02       Impact factor: 5.810

2.  Effects of modified Sanhuang decoction () enema on serum tumor necrosis factor-α and colonic mucosa interleukin-1β, interleukin-6 levels in ulcerative colitis rats.

Authors:  Shuai Wang; Tao Zhou; Jun-Peng Zhai; Li-Hua Wang; Jing Chen
Journal:  Chin J Integr Med       Date:  2013-10-14       Impact factor: 1.978

3.  Comparison of different methods of intestinal obstruction in a rat model.

Authors:  Meng-Lang Yuan; Zheng Yang; Yu-Cheng Li; Lan-Lan Shi; Jia-Ling Guo; Yu-Qin Huang; Xia Kang; Jing-Jing Cheng; Yang Chen; Ting Yu; De-Qi Cao; Huan Pang; Xiao Zhang
Journal:  World J Gastroenterol       Date:  2013-02-07       Impact factor: 5.742

Review 4.  Reevaluating the hype: four bacterial metabolites under scrutiny.

Authors:  E E Fröhlich; R Mayerhofer; P Holzer
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-03-26

5.  Dairy milk fat augments paclitaxel therapy to suppress tumour metastasis in mice, and protects against the side-effects of chemotherapy.

Authors:  Xueying Sun; Jie Zhang; Rita Gupta; Alastair K H Macgibbon; Barbara Kuhn-Sherlock; Geoffrey W Krissansen
Journal:  Clin Exp Metastasis       Date:  2011-07-08       Impact factor: 5.150

6.  Mucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colon.

Authors:  A Barcelo; J Claustre; F Moro; J A Chayvialle; J C Cuber; P Plaisancié
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

7.  Activation of nuclear factor-kappa B and effects of pyrrolidine dithiocarbamate on TNBS-induced rat colitis.

Authors:  Ken Chen; You-Ming Long; Hui Wang; Lei Lan; Zhen-He Lin
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

8.  The gut fermentation product butyrate, a chemopreventive agent, suppresses glutathione S-transferase theta (hGSTT1) and cell growth more in human colon adenoma (LT97) than tumor (HT29) cells.

Authors:  Tanja Kautenburger; Gabriele Beyer-Sehlmeyer; Grit Festag; Natja Haag; Stephanie Kühler; Alma Küchler; Anja Weise; Brigitte Marian; Wilbert H M Peters; Thomas Liehr; Uwe Claussen; Beatrice L Pool-Zobel
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-20       Impact factor: 4.553

9.  Modulation of the effect of dextran sulfate sodium-induced acute colitis by the administration of different probiotic strains of Lactobacillus and Bifidobacterium.

Authors:  Nadia Osman; Diya Adawi; Siv Ahrne; Bengt Jeppsson; Göran Molin
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199

10.  n3 PUFAs reduce mouse CD4+ T-cell ex vivo polarization into Th17 cells.

Authors:  Jennifer M Monk; Tim Y Hou; Harmony F Turk; David N McMurray; Robert S Chapkin
Journal:  J Nutr       Date:  2013-07-17       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.